Telomir Pharmaceuticals is a preclinical stage company focused on the science of lengthening telomere caps, which the company believes will extend human lifespans and improve quality of life as people age. The company released test results that showed Telomir-1 reverses multiple signs of cellular decline across human cell lines. This provides a foundation for the company to pursue treatments of autism and spasmodic dysphonia.
